MX2009013729A - Imidazopirazinas como inhibidores de proteina quinasa. - Google Patents

Imidazopirazinas como inhibidores de proteina quinasa.

Info

Publication number
MX2009013729A
MX2009013729A MX2009013729A MX2009013729A MX2009013729A MX 2009013729 A MX2009013729 A MX 2009013729A MX 2009013729 A MX2009013729 A MX 2009013729A MX 2009013729 A MX2009013729 A MX 2009013729A MX 2009013729 A MX2009013729 A MX 2009013729A
Authority
MX
Mexico
Prior art keywords
compounds
imidazopyrazines
protein kinase
kinase inhibitors
methods
Prior art date
Application number
MX2009013729A
Other languages
English (en)
Inventor
M Arshad Siddiqui
David B Belanger
Patrick J Curran
Jayaram R Tagat
Yushi Xiao
Angela D Kerekes
Tao Yu
Ronald Doll
Zhaoyang Meng
Sara J Esposite
Amit K Mandal
Bheemashankar A Kulkarni
Yonglian Zhang
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40002934&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009013729(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX2009013729A publication Critical patent/MX2009013729A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

En sus muchas modalidades, la presente invención proporciona una nueva clase de compuestos de imidazopirazina como inhibidores de proteínas y/o Aurora quinasas, métodos de preparación de dichos compuestos, composiciones farmacéuticas que incluyen uno o más de dichos compuestos, métodos de preparación de formulaciones farmacéuticas que incluyen uno o más de dichos compuestos, y métodos de tratamiento, prevención, inhibición, o mejoramiento de una o más enfermedades asociadas con las proteínas o Aurora quinasas que utilizan dichos compuestos composiciones farmacéuticas.
MX2009013729A 2007-06-14 2008-06-11 Imidazopirazinas como inhibidores de proteina quinasa. MX2009013729A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94399907P 2007-06-14 2007-06-14
US98793207P 2007-11-14 2007-11-14
PCT/US2008/007295 WO2008156614A2 (en) 2007-06-14 2008-06-11 Imidazopyrazines as protein kinase inhibitors

Publications (1)

Publication Number Publication Date
MX2009013729A true MX2009013729A (es) 2010-01-25

Family

ID=40002934

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009013729A MX2009013729A (es) 2007-06-14 2008-06-11 Imidazopirazinas como inhibidores de proteina quinasa.

Country Status (10)

Country Link
EP (1) EP2170892A2 (es)
JP (1) JP2010529195A (es)
CN (1) CN101772500A (es)
AR (1) AR066958A1 (es)
CA (1) CA2690557A1 (es)
CL (1) CL2008001745A1 (es)
MX (1) MX2009013729A (es)
PE (1) PE20090365A1 (es)
TW (1) TW200911811A (es)
WO (1) WO2008156614A2 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2756759C (en) 2009-04-16 2017-11-07 Joaquin Pastor Fernandez Imidazopyrazines for use as kinase inhibitors
TW201107329A (en) * 2009-07-30 2011-03-01 Oncotherapy Science Inc Fused imidazole derivative having ttk inhibitory action
WO2011028638A1 (en) 2009-09-04 2011-03-10 Schering Corporation Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
ES2651296T3 (es) 2009-10-30 2018-01-25 Janssen Pharmaceutica, N.V. Derivados de imidazo[1,2-b]piridacina y su uso como inhibidores de PDE10
AR080754A1 (es) 2010-03-09 2012-05-09 Janssen Pharmaceutica Nv Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
CA2801031A1 (en) * 2010-06-01 2011-12-08 Bayer Intellectual Property Gmbh Substituted imidazopyrazines
ES2541054T3 (es) * 2010-10-20 2015-07-15 Université De Bordeaux Firmas del resultado clínico en tumores estromales gastrointestinales y método de tratamiento de tumores estromales gastrointestinales
EP2444084A1 (en) 2010-10-21 2012-04-25 Centro Nacional de Investigaciones Oncológicas (CNIO) Use of PI3K inibitors for the treatment of obesity
WO2012052745A1 (en) 2010-10-21 2012-04-26 Centro Nacional De Investigaciones Oncológicas (Cnio) Combinations of pi3k inhibitors with a second anti -tumor agent
CA2821834A1 (en) * 2010-12-17 2012-06-21 Bayer Intellectual Property Gmbh 6 substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
US8673905B2 (en) * 2011-03-17 2014-03-18 Hoffmann-La Roche Inc. Imidazo pyrazines
US9346795B2 (en) 2011-05-25 2016-05-24 Bristol-Myers Squibb Company Substituted sulfonamides useful as antiapoptotic Bcl inhibitors
MX344600B (es) 2011-06-27 2016-12-20 Janssen Pharmaceutica Nv Derivados de 1-aril-4-metil-[1,2,4]triazolo[4,3-a]quinoxalina.
EP2863909B1 (en) 2012-06-26 2020-11-04 Janssen Pharmaceutica N.V. Combinations comprising 4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline compounds as pde 2 inhibitors and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders
AU2013289284B2 (en) 2012-07-09 2017-03-30 Janssen Pharmaceutica Nv Inhibitors of phosphodiesterase 10 enzyme
IL294895B2 (en) 2014-01-13 2023-10-01 Aurigene Oncology Ltd History of bicyclic heterocyclyls as IRAK4 inhibitors
US9493442B2 (en) 2014-02-13 2016-11-15 Incyte Corporation Cyclopropylamines as LSD1 inhibitors
CR20200362A (es) 2014-02-13 2020-10-26 Incyte Corp CICLOPROPILAMINA COMO INHIBIDORES DE LA LSD1 (Divisional 2016-0395)
US9527835B2 (en) 2014-02-13 2016-12-27 Incyte Corporation Cyclopropylamines as LSD1 inhibitors
HUE046273T2 (hu) 2014-02-13 2020-02-28 Incyte Corp Ciklopropilaminok mint LSD1 inhibitorok
US9695168B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors
US9758523B2 (en) 2014-07-10 2017-09-12 Incyte Corporation Triazolopyridines and triazolopyrazines as LSD1 inhibitors
TW201613925A (en) 2014-07-10 2016-04-16 Incyte Corp Imidazopyrazines as LSD1 inhibitors
US9695167B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors
US9944647B2 (en) 2015-04-03 2018-04-17 Incyte Corporation Heterocyclic compounds as LSD1 inhibitors
JP7427363B2 (ja) 2015-08-12 2024-02-05 インサイト・ホールディングス・コーポレイション Ｌｓｄ１阻害剤の塩
ES2963148T3 (es) 2016-04-22 2024-03-25 Incyte Corp Formulaciones de un inhibidor de LSD1
US11690847B2 (en) 2016-11-30 2023-07-04 Case Western Reserve University Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof
AU2018215678A1 (en) 2017-02-06 2019-08-22 Board Of Regents Of The University Of Texas System Compositions and methods of modulating short-chain dehydrogenase activity
EP3600270B1 (en) * 2017-03-31 2023-06-14 Aurigene Oncology Limited Compounds and compositions for treating hematological disorders
CN107954977A (zh) * 2017-12-15 2018-04-24 上海鼎雅药物化学科技有限公司 雷替曲塞中间体的合成方法
WO2020047198A1 (en) 2018-08-31 2020-03-05 Incyte Corporation Salts of an lsd1 inhibitor and processes for preparing the same
CN115702156A (zh) * 2021-04-23 2023-02-14 南京明德新药研发有限公司 吡啶酰胺类化合物
WO2023169438A1 (zh) * 2022-03-07 2023-09-14 上海凌达生物医药有限公司 一类含氮杂环类细胞周期抑制剂化合物、制备方法和用途
WO2024088192A1 (en) * 2022-10-26 2024-05-02 Js Innopharm (Suzhou) Ltd. An aurora a inhibitor for use in treatments of cancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576085B2 (en) * 2002-09-23 2009-08-18 Schering Corporation Imidazopyrazines as cyclin dependent kinase inhibitors
KR20050057520A (ko) * 2002-09-23 2005-06-16 쉐링 코포레이션 사이클린 의존성 키나제 억제제로서의 이미다조피라진
CA2587192A1 (en) * 2004-11-10 2006-05-18 Cgi Pharmaceuticals, Inc. Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity
CN101370811A (zh) * 2005-11-10 2009-02-18 先灵公司 作为蛋白激酶抑制剂的咪唑并吡嗪化合物

Also Published As

Publication number Publication date
JP2010529195A (ja) 2010-08-26
CL2008001745A1 (es) 2008-12-05
TW200911811A (en) 2009-03-16
PE20090365A1 (es) 2009-04-04
WO2008156614A3 (en) 2009-02-12
EP2170892A2 (en) 2010-04-07
CA2690557A1 (en) 2008-12-24
WO2008156614A2 (en) 2008-12-24
CN101772500A (zh) 2010-07-07
AR066958A1 (es) 2009-09-23

Similar Documents

Publication Publication Date Title
MX2009013729A (es) Imidazopirazinas como inhibidores de proteina quinasa.
WO2007058942A3 (en) Imidazopyrazines as protein kinase inhibitors
WO2010088368A3 (en) Imidazopyrazines as protein kinase inhibitors
MX2009005011A (es) Imidazopirazinas como inhibidores de proteina quinasa.
TW200745128A (en) Pyrazolopyrimidines as protein kinase inhibitors
TW200745127A (en) Pyrazolopyrimidines as protein kinase inhibitors
MX2009011355A (es) Nuevas pirazolopirimidinas como inhibidores de quinasas dependientes de ciclinas.
TW200745123A (en) Pyrazolopyrimidines as protein kinase inhibitors
MX2009003734A (es) Pirazolopirimidinas como inhibidor de cinasas dependientes de ciclina.
TW200801008A (en) Protein kinase inhibitors
ZA200707342B (en) Pyrrolopyrimidines useful as inhibitors of protein kinase
MY149044A (en) Pyrazolopyrimidines - derivatives as cyclin dependent kinase inhibitors
GEP20115283B (en) Pyrrolopyrimidine compounds and their uses
HK1112233A1 (en) Pyrazolopyrimidines as cyclin dependent kinase inhibitors for the treatment of cancer
MX2009003733A (es) Pirazolopirimidinas como inhibidores de quinasas dependientes de ciclina.
WO2007058873A3 (en) Imidazopyrazines as cyclin depentend kinase inhibitors
MY162134A (en) Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
SG151327A1 (en) Deazapurines useful as inhibitors of janus kinases
WO2007087068A3 (en) Inhibitors of tyrosine kinases and uses thereof
WO2007044401A3 (en) Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
WO2007011962A3 (en) Treatment of cancer
UA95940C2 (uk) Азаіндоли як інгібітори кіназ януса
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
WO2008045267A3 (en) Pyrazolopyrimidines as cyclin dependent kinase inhibitors
TW200604192A (en) Compounds and methods for inhibiting mitotic progression

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal